Resolve Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series B3

  • Latest Deal Amount
  • $18M

  • Investors
  • 6

Resolve Therapeutics General Information

Description

Operator of a biotechnology company intended to help clients develop biologic therapies in clinical development for autoimmune diseases. The company specializes in developing new treatments for systemic lupus erythematosus and Sjogren's syndrome, enabling patients to find immediate treatment for such diseases and live a healthy life.

Contact Information

Website
www.resolvetherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 721 1st Avenue North
  • Saint Petersburg, FL 33701
  • United States
+1 (208)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 721 1st Avenue North
  • Saint Petersburg, FL 33701
  • United States
+1 (208)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resolve Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B3) 02-Jan-2018 $18M Completed Clinical Trials - Phase 3
4. Later Stage VC (Series B2) 01-Oct-2016 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B1) 01-Nov-2012 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 13-May-2011 $2M $2M Completed Clinical Trials - Phase 2
1. University Spin-Out 01-Jan-2010 Completed Startup
To view Resolve Therapeutics’s complete valuation and funding history, request access »

Resolve Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to help clients develop biologic therapies in clinical development for auto
Biotechnology
Saint Petersburg, FL
25 As of 2022

South San Francisco, CA
 

Princeton, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resolve Therapeutics Competitors (7)

One of Resolve Therapeutics’s 7 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Bristol-Myers Squibb Corporation Princeton, NJ
Boehringer Ingelheim Corporation Ingelheim Am Rhein, Germany
Amgen Formerly PE-Backed Thousand Oaks, CA
Merck & Co. Corporation Rahway, NJ
You’re viewing 5 of 7 competitors. Get the full list »

Resolve Therapeutics Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 18

    Pending

  • Expiring in next 12 mo

Resolve Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4171614-A1 Treatment of sjogren's syndrome with nuclease fusion proteins Pending 29-Jun-2020
US-20230355722-A1 Treatment of sjogren’s syndrome with nuclease fusion proteins Pending 29-Jun-2020
CA-3165342-A1 Treatment of sjogren's syndrome with nuclease fusion proteins Pending 29-Jun-2020
CA-3124352-A1 Treatment of sjogren's disease with nuclease fusion proteins Pending 04-Jan-2019
EP-3906062-A1 Treatment of sjogren's disease with nuclease fusion proteins Pending 04-Jan-2019 C07K16/462
To view Resolve Therapeutics’s complete patent history, request access »

Resolve Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resolve Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
WRF Capital Venture Capital Minority
Easton Capital Investment Group Venture Capital Minority
New Science Ventures Venture Capital Minority
University of Washington University
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Resolve Therapeutics FAQs

  • When was Resolve Therapeutics founded?

    Resolve Therapeutics was founded in 2010.

  • Where is Resolve Therapeutics headquartered?

    Resolve Therapeutics is headquartered in Saint Petersburg, FL.

  • What is the size of Resolve Therapeutics?

    Resolve Therapeutics has 25 total employees.

  • What industry is Resolve Therapeutics in?

    Resolve Therapeutics’s primary industry is Biotechnology.

  • Is Resolve Therapeutics a private or public company?

    Resolve Therapeutics is a Private company.

  • What is Resolve Therapeutics’s current revenue?

    The current revenue for Resolve Therapeutics is .

  • How much funding has Resolve Therapeutics raised over time?

    Resolve Therapeutics has raised $36.8M.

  • Who are Resolve Therapeutics’s investors?

    , WRF Capital, Easton Capital Investment Group, New Science Ventures, and University of Washington are 5 of 6 investors who have invested in Resolve Therapeutics.

  • Who are Resolve Therapeutics’s competitors?

    Genentech, Bristol-Myers Squibb, Boehringer Ingelheim, Amgen, and Merck & Co. are some of the 7 competitors of Resolve Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »